These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 21830904
1. Recombinant MVA expressing secreted glycoprotein D of BoHV-1 induces systemic and mucosal immunity in animal models. Ferrer MF, Del Médico Zajac MP, Zanetti FA, Valera AR, Zabal O, Calamante G. Viral Immunol; 2011 Aug; 24(4):331-9. PubMed ID: 21830904 [Abstract] [Full Text] [Related]
2. Induction of Both Local Immune Response in Mice and Protection in a Rabbit Model by Intranasal Immunization with Modified Vaccinia Ankara Virus Expressing a Secreted Form of Bovine Herpesvirus 1 Glycoprotein D. Del Medico Zajac MP, Zanetti FA, Esusy MS, Federico CR, Zabal O, Valera AR, Calamante G. Viral Immunol; 2017 Aug; 30(1):70-76. PubMed ID: 27809679 [Abstract] [Full Text] [Related]
3. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice. Caselli E, Boni M, Di Luca D, Salvatori D, Vita A, Cassai E. Comp Immunol Microbiol Infect Dis; 2005 Mar; 28(2):155-66. PubMed ID: 15582691 [Abstract] [Full Text] [Related]
4. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J. Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689 [Abstract] [Full Text] [Related]
8. A chimeric baculovirus displaying bovine herpesvirus-1 (BHV-1) glycoprotein D on its surface and their immunological properties. Peralta A, Molinari P, Conte-Grand D, Calamante G, Taboga O. Appl Microbiol Biotechnol; 2007 May 25; 75(2):407-14. PubMed ID: 17285288 [Abstract] [Full Text] [Related]
9. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection. Parez N, Fourgeux C, Mohamed A, Dubuquoy C, Pillot M, Dehee A, Charpilienne A, Poncet D, Schwartz-Cornil I, Garbarg-Chenon A. J Virol; 2006 Feb 25; 80(4):1752-61. PubMed ID: 16439532 [Abstract] [Full Text] [Related]
10. Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer. Kalthoff D, König P, Trapp S, Beer M. Vaccine; 2010 Aug 16; 28(36):5871-7. PubMed ID: 20600486 [Abstract] [Full Text] [Related]
16. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies. Weyer J, Rupprecht CE, Mans J, Viljoen GJ, Nel LH. Vaccine; 2007 May 22; 25(21):4213-22. PubMed ID: 17434244 [Abstract] [Full Text] [Related]
17. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection. Singh SR, Hulett K, Pillai SR, Dennis VA, Oh MK, Scissum-Gunn K. Vaccine; 2006 Feb 20; 24(8):1213-24. PubMed ID: 16194585 [Abstract] [Full Text] [Related]
18. Genetic immunisation of cattle against bovine herpesvirus 1: glycoprotein gD confers higher protection than glycoprotein gC or tegument protein VP8. Toussaint JF, Coen L, Letellier C, Dispas M, Gillet L, Vanderplasschen A, Kerkhofs P. Vet Res; 2005 Feb 20; 36(4):529-44. PubMed ID: 15955279 [Abstract] [Full Text] [Related]
19. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4. McCurdy LH, Rutigliano JA, Johnson TR, Chen M, Graham BS. J Virol; 2004 Nov 20; 78(22):12471-9. PubMed ID: 15507634 [Abstract] [Full Text] [Related]
20. Bovine herpesvirus 1 VP22 enhances the efficacy of a DNA vaccine in cattle. Zheng C, Babiuk LA, van Drunen Littel-van den Hurk S. J Virol; 2005 Feb 20; 79(3):1948-53. PubMed ID: 15650221 [Abstract] [Full Text] [Related] Page: [Next] [New Search]